2025-12-03 - Analysis Report
Okay, here's a breakdown of the provided Procter & Gamble (PG) data, combining the numbers and analysis as requested.

**Procter & Gamble Co. (PG) Overview:** Procter & Gamble is a multinational consumer goods corporation.

**1. Return Comparison & Alpha/Beta Analysis:**

*   **Cumulative Return (PG):** 27.22%
*   **Cumulative Return (VOO - S&P 500):** 100.36%
*   **Divergence:** -72.3 (Relative Divergence: 1.7)

**Analysis:** PG has significantly underperformed the S&P 500 over the period analyzed. The large negative divergence indicates a substantial difference in returns, with PG lagging considerably. The relative divergence of 1.7 suggests the current divergence is near the lower end of its historical range.

**Alpha, Beta and CAGR Analysis:**

| Year       | CAGR     | MDD    | Alpha   | Beta   | Cap(B) |
|------------|----------|--------|---------|--------|--------|
| 2015-2017  | 21.0%    | 7.9%   | -8.0%   | 0.0    | 215.1  |
| 2016-2018  | 9.0%     | 67.3%  | -6.0%   | 0.1    | 215.2  |
| 2017-2019  | 24.0%    | 70.4%  | 2.0%    | 0.3    | 292.4  |
| 2018-2020  | 27.0%    | 78.8%  | 4.0%    | 0.4    | 325.7  |
| 2019-2021  | 41.0%    | 78.8%  | -5.0%   | 0.5    | 382.9  |
| 2020-2022  | 13.0%    | 79.4%  | 13.0%   | 0.6    | 354.8  |
| 2021-2023  | 26.0%    | 79.4%  | 24.0%   | 0.4    | 343.1  |
| 2022-2024  | 9.0%     | 79.4%  | -12.0%  | 0.4    | 392.5  |
| 2023-2025  | -17.0%   | 80.1%  | -82.0%  | 0.2    | 341.1  |

*   **CAGR:** Fluctuates, with a negative CAGR in the most recent period (2023-2025).
*   **MDD:** High Maximum Drawdown (MDD) values indicate significant potential for loss, particularly in more recent periods.
*   **Alpha:** Shows periods of both outperformance and underperformance relative to the market (S&P 500). The recent period (2023-2025) shows significant underperformance (large negative Alpha).
*   **Beta:** Beta values are relatively low, suggesting PG's price is less volatile than the overall market.

**2. Recent Stock Price Fluctuations:**

*   **Current Price:** 145.71
*   **Last Market Data:** Price 145.77, Previous Close 147.44, Change -1.13
*   **5-day SMA:** 147.518
*   **20-day SMA:** 147.3715
*   **60-day SMA:** 151.088

**Analysis:** The stock price is currently below all three Simple Moving Averages (SMA). This *could* indicate a short-term downtrend. The negative change in the last market data reinforces this.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 50.55 (Neutral)
*   **PPO:** 0.08 (Positive but low)
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change (20 days):** -9.2 (Negative trend)
*   **Expected Return (%):** 52.9 (Excess Return Compared to S&P 500, long-term)

**Analysis:**

*   The MRI suggests a generally favorable investment environment (High Investment Recommended). However, this should be considered in the context of other indicators.
*   The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The PPO is slightly positive, suggesting a potential uptrend, but its low value makes this less conclusive.
*   The hybrid signal suggests a buying opportunity.
*   The negative divergence change indicates recent underperformance relative to the S&P 500.
*   The high Expected Return is a positive factor, assuming it is reliably calculated, and the investor has a long-term investment horizon.

**4. Recent News & Significant Events:**

*   **General Investor Interest:** "Investors Heavily Search Procter & Gamble Company" suggests increased attention, potentially driven by recent price movements.
*   **Consumer Concerns:** "Procter & Gamble Stock Drops. Its CFO Says Consumers Are Nervous" and "Procter & Gamble Stock Tests Two-Year Low After CFO Sounds Warning on Consumers" are concerning headlines, indicating potential headwinds for the company due to economic uncertainty or changing consumer behavior.
*   **Stock Performance:** "Procter & Gamble (PG) Stock: Shares Hit 52-Week Low" and "Procter & Gamble stock hits 52-week low at 144.04 USD" confirm recent price weakness.
*   **Earnings Discussion:** "Procter & Gamble Stock (PG) Opinions on Q1 FY26 Earnings and Price Decline" implies that recent earnings may be a factor in the stock's current performance.

**Analysis:** The news headlines are predominantly negative, focusing on stock price declines, consumer anxieties, and potential concerns related to earnings. This could be contributing to investor uncertainty.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~2.00)
*   **Target Price:** 169.05 (Average), 186.00 (High), 148.00 (Low)
*   **Recent Rating Changes:** None reported (empty entries)

**Analysis:** Despite the recent negative news and stock performance, analyst consensus remains at "Buy" with a target price significantly above the current price. This suggests analysts believe the stock is undervalued and expect a future price increase. It's important to consider that analysts' estimates may not always be accurate.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-10-24 | 2.00 | 22.39 B$      |
| 2025-04-24 | 1.58 | 19.78 B$      |
| 2025-01-22 | 1.94 | 21.88 B$      |
| 2024-10-18 | 1.65 | 21.74 B$      |
| 2025-10-24 | 1.65 | 21.74 B$      |

**Analysis:**  While revenue fluctuates, there isn't a clear, consistent trend. It is worth noting the table has duplicate date entry.

**6. Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|----------------|
| 2025-09-30   | $22.39B   | 51.37%         |
| 2025-06-30   | $20.89B   | 49.11%         |
| 2025-03-31   | $19.78B   | 50.98%         |
| 2024-12-31   | $21.88B   | 52.39%         |
| 2024-09-30   | $21.74B   | 52.06%         |

Capital and Profitability:

| Quarter      | Equity      | ROE      |
|--------------|-------------|----------|
| 2025-09-30   | $53.27B    | 8.92%    |
| 2025-06-30   | $52.01B    | 6.95%    |
| 2025-03-31   | $52.27B    | 7.21%    |
| 2024-12-31   | $51.17B    | 9.05%    |
| 2024-09-30   | $51.84B    | 7.64%    |

**Analysis:**

*   **Revenue:** Fluctuates, with the most recent quarter showing the highest revenue in the presented data.
*   **Profit Margin:** Relatively stable, generally around 50-52%, indicating strong profitability.
*   **Equity:** Increasing slightly over the past few quarters.
*   **ROE:**  Also fluctuates, indicating variations in profitability relative to equity. The ROE for the latest quarter (2025-09-30) is at 8.92%.

**7. Comprehensive Analysis:**

PG has underperformed the S&P 500 significantly, and its stock price has recently hit a 52-week low. The CFO's warning about nervous consumers is a concern. However, analyst consensus remains a "Buy," and the financial data shows relatively stable revenue and strong profit margins. The MRI suggests a generally favorable investment environment, while the Hybrid Signal recommends buying.

**Overall Assessment:**

The situation is mixed. While the recent stock performance and news headlines are concerning, the underlying financials and analyst opinions offer some encouragement. The high "Expected Return" also warrants consideration.

**Investment Recommendation:**

Based on the provided data, a conservative investor may want to wait and see how the consumer sentiment plays out and monitor the stock's performance in the coming weeks. Aggressive investors may see this as a buying opportunity, especially if they believe the company's fundamentals remain strong and the stock is currently undervalued.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.